Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) Share Price

Company Profile

Business description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
Contact
No. 1386 Hongqiao Road
23rd Floor, WenGuang Plaza
Changning District
Shanghai
CHN
T: +86 2152293555
https://www.3healthcare.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2,156

Recommended

We were wrong when we thought last quarter would be hard to top.

Dan Romanoff, CPA | 31 July 2025

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,999.00	16.40	-0.18%
CAC 40	7,813.80	48.16	-0.61%
DAX 40	24,175.29	86.93	-0.36%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,152.16	15.22	0.17%
HKSE	24,773.33	403.60	-1.60%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	41,069.82	415.12	1.02%
NZX 50 Index	12,823.74	32.23	-0.25%
S&P 500	6,362.90	0.00	0.00%
S&P/ASX 200	8,742.80	13.60	-0.16%
SSE Composite Index	3,573.21	42.51	-1.18%